$2125 | SAVE $375 | Single User
$4250 | SAVE $750 | Site License
$6375 | SAVE $1,125 | Enterprise License

High-Grade Glioma Global Clinical Trials Review, H1, 2016
[Published by Global Data]

Published by Global Data: 15 Jun 2016 | 27009 | In Stock
Related Topics: Clinical Trials

Introduction

High-Grade Glioma Global Clinical Trials Review, H1, 2016

Summary

GlobalData's clinical trial report, “High-Grade Glioma Global Clinical Trials Review, H1, 2016" provides an overview of High-Grade Glioma clinical trials scenario. This report provides top line data relating to the clinical trials on High-Grade Glioma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents
for High-Grade Glioma Global Clinical Trials Review, H1, 2016 [Published by Global Data]

  • Table of Contents

    Table of Contents 2

    List of Tables 3

    List of Figures 4

    Report Guidance 5

    Clinical Trials by Region 6

    Clinical Trials and Average Enrollment by Country 7

    Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9

    Top Five Countries Contributing to Clinical Trials in Europe 10

    Top Countries Contributing to Clinical Trials in North America 11

    Top Countries Contributing to Clinical Trials in Middle East and Africa 12

    Clinical Trials by G7 Countries: Proportion of High-Grade Glioma to Oncology Clinical Trials 13

    Clinical Trials by Phase in G7 Countries 14

    Clinical Trials in G7 Countries by Trial Status 15

    Clinical Trials by E7 Countries: Proportion of High-Grade Glioma to Oncology Clinical Trials 16

    Clinical Trials by Phase in E7 Countries 17

    Clinical Trials in E7 Countries by Trial Status 18

    Clinical Trials by Phase 19

    In Progress Trials by Phase 20

    Clinical Trials by Trial Status 21

    Clinical Trials by End Point Status 22

    Subjects Recruited Over a Period of Time 23

    Clinical Trials by Sponsor Type 24

    Prominent Sponsors 25

    Top Companies Participating in High-Grade Glioma Therapeutics Clinical Trials 26

    Prominent Drugs 27

    Latest Clinical Trials News on High-Grade Glioma 28

    May 13, 2016: Tocagen to Present Clinical and Preclinical Data at Three Scientific Meetings 28

    May 03, 2016: Tocagen Presents Intravenous Toca 511 Clinical Data at the 84th AANS Annual Scientific Meeting 28

    Apr 13, 2016: Tocagen to Present Data from Clinical Trials and Preclinical Programs at Four Scientific Conferences 29

    Clinical Trial Profile Snapshots 30

    Appendix 194

    Abbreviations 194

    Definitions 194

    Research Methodology 195

    Secondary Research 195

    About GlobalData 196

    Contact Us 196

    Disclaimer 196

    Source 197

List Of Tables
in High-Grade Glioma Global Clinical Trials Review, H1, 2016 [Published by Global Data]

List of Tables

High-Grade Glioma Therapeutics, Global, Clinical Trials by Region, 2016* 6

High-Grade Glioma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7

High-Grade Glioma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8

High-Grade Glioma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9

High-Grade Glioma Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10

High-Grade Glioma Therapeutics Clinical Trials, North America, Top Countries, 2016* 11

High-Grade Glioma Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 12

Proportion of High-Grade Glioma to Oncology Clinical Trials, G7 Countries (%), 2016* 13

High-Grade Glioma Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14

High-Grade Glioma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15

Proportion of High-Grade Glioma to Oncology Clinical Trials, E7 Countries (%), 2016* 16

High-Grade Glioma Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 17

High-Grade Glioma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 18

High-Grade Glioma Therapeutics, Global, Clinical Trials by Phase, 2016* 19

High-Grade Glioma Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 20

High-Grade Glioma Therapeutics, Global, Clinical Trials by Trial Status, 2016* 21

High-Grade Glioma Therapeutics Clinical Trials, Global, by End Point Status, 2016* 22

High-Grade Glioma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 23

High-Grade Glioma Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 24

High-Grade Glioma Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 25

High-Grade Glioma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 26

High-Grade Glioma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 27

List Of Figures, Charts and Diagrams
in High-Grade Glioma Global Clinical Trials Review, H1, 2016 [Published by Global Data]

List of Figures

High-Grade Glioma Therapeutics, Global, Clinical Trials by Region (%), 2016* 6

High-Grade Glioma Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7

High-Grade Glioma Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8

High-Grade Glioma Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9

High-Grade Glioma Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10

High-Grade Glioma Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11

High-Grade Glioma Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016* 12

Proportion of High-Grade Glioma to Oncology Clinical Trials, G7 Countries (%), 2016* 13

High-Grade Glioma Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 14

High-Grade Glioma Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 15

Proportion of High-Grade Glioma to Oncology Clinical Trials, E7 Countries (%), 2016* 16

High-Grade Glioma Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 17

High-Grade Glioma Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 18

High-Grade Glioma Therapeutics, Global, Clinical Trials by Phase (%), 2016* 19

High-Grade Glioma Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 20

High-Grade Glioma Therapeutics, Global, Clinical Trials by Trial Status, 2016* 21

High-Grade Glioma Therapeutics Clinical Trials, Global, by End Point Status, 2016* 22

High-Grade Glioma Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 23

High-Grade Glioma Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 24

High-Grade Glioma Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 25

High-Grade Glioma Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 26

High-Grade Glioma Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 27

GlobalData Methodology 195

Additional Details

Publisher

Global Data

Publisher Information

Reference

27009 | GDHC3476CTIDB

Number of Pages

197

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
SAVE 15% today! ChemRar High-Tech Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryChemRar High-Tech Center (CHTC) is a biotechnology company that discovers, develops and comme...
24 Aug 2016 by Global Data USD $213 (normally
USD $251)
More Info
SAVE 15% today! Hitachi High-Technologies Corporation (8036) - Medical Equipment - Deals and Alliances Profile
SummaryHitachi High-Technologies Corporation (Hitachi High-Tech), a subsidiary of Hitachi, Ltd. is a...
28 Jul 2016 by Global Data USD $213 (normally
USD $251)
More Info
SAVE 15% today! High-Grade Glioma Global Clinical Trials Review, H1, 2016
High-Grade Glioma Global Clinical Trials Review, H1, 2016SummaryGlobalData's clinical trial report, ...
15 Jun 2016 by Global Data USD $2,125 (normally
USD $2,500)
More Info
SAVE 15% today! ChemRar High-Tech Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryChemRar High-Tech Center (CHTC) is a biotechnology company that discovers, develops, and comm...
06 May 2016 by Global Data USD $213 (normally
USD $251)
More Info
SAVE 15% today! Hitachi High-Technologies Corporation (8036) - Medical Equipment - Deals and Alliances Profile
SummaryHitachi High-Technologies Corporation (Hitachi High-Tech) a subsidiary of Hitachi, Ltd. is a ...
05 Apr 2016 by Global Data USD $213 (normally
USD $251)
More Info
SAVE 15% today! ChemRar High-Tech Center - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryChemRar High-Tech Center (CHTC) is a biotechnology company that discovers, develops, and comm...
10 Mar 2016 by Global Data USD $213 (normally
USD $251)
More Info
SAVE 15% today! High Content Screening Trends 2016
HTStec's High Content Screening Trends 2016 report was published on 3 February 2016. This 54 page ma...
03 Mar 2016 by HTStec USD $1,700 (normally
USD $2,000)
More Info
SAVE 15% today! Hitachi High-Technologies Corporation (8036) - Medical Equipment - Deals and Alliances Profile
SummaryHitachi High-Technologies Corporation (Hitachi High-Tech) a subsidiary of Hitachi, Ltd. is a ...
25 Feb 2016 by Global Data USD $213 (normally
USD $251)
More Info
SAVE 15% today! Human Microbiome Market by Indication (Obesity, Cancer), Application (Therapeutic, Diagnostic), Product (Prebiotics, Food, Drugs), Product Research (Instruments, Consumables), Technology Research (High Throughput, Omics Technology) - Global Forecast to 2023
The product segment is expected to account for the largest share of the human microbiome market in t...
12 Jan 2016 by MarketsandMarkets USD $3,953 (normally
USD $4,651)
More Info
SAVE 15% today! High Throughput Flow Assay Trends 2015
HTStec's High Throughput Flow Assay Trends 2015 report was published on 2 January 2015. This 55 page...
02 Jan 2015 by HTStec USD $1,700 (normally
USD $2,000)
More Info

This report is published by Global Data

Download Free Report Summary PDF

High-Grade Glioma Global Clinical Trials Review, H1, 2016 [Published by Global Data] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...